GIS vs TARS · P/E 8.2, rev $18.42B vs rev $336.0M
General Mills Inc (GIS) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. TARS currently screens at market cap $2.66B.
Not investment advice. Open the GIS and TARS stock pages for the full models.
Not investment advice.